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Continuous Directed Evolution of Enzymes with Novel Substrate Specificity
Abstract
 Methodological advances in directed evolution have already made it possible to discover 
useful biomolecules within months to years.  A further acceleration of this process might make it 
possible to address outstanding challenges, or needs for which the current timescale is a 
fundamental barrier.  To realize these goals would require transformative methodological 
advances in directed evolution.
 In Chapter One, current methods in directed evolution are briefly reviewed.  In Chapter 
Two, a general platform for continuous directed evolution is presented.  The method is used to 
evolve T7 RNA polymerase enzymes with novel promoter activity on the days timescale.  In 
Chapter Three, a method is developed for tuning selection stringency during continuous 
evolution, thus obviating the requirement for a minimal starting library activity.  In Chapter Four, 
a method is developed for simultaneous positive and negative selection, thus allowing explicit 
selection for substrate specific enzymes.  In Chapter Five, the advances in stringency modulation 
and negative selection are combined to evolve highly substrate specific enzymes starting from an 
inactive starting library.  In a continuous evolutionary arc of less than three days, we discover T7 
RNA polymerase enzymes with a degree of specificity for the T3 promoter exceeding that of the 
wild type enzyme for its native substrate.
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Chapter One
Introduction
1.1 Introduction
 Directed evolution mimics nature’s cycle of diversification, selection, and amplification 
to discover biomolecules with novel properties; an evolving molecule is “directed” toward a new 
goal for which selection pressure may not exist in nature1.  In the diversification stage, a parent 
gene undergoes mutation to create a “library” of candidate genes, of which some small fraction 
potentially encode molecules with improved properties.  This library is then interrogated, by 
screening or selection, to identify or enrich variants with the desired property.  Finally, the output 
of this stage is amplified, recovered for analysis, and resubjected to diversification.  This 
laboratory evolution scheme can be used to dramatically improve protein activity toward a 
variety of user-defined criteria.  Two recent examples – far-red fluorescent proteins2, and site 
selective transpeptidases3 – illustrate some key principles of the modern art (Figure 1.1).
 Lin et. al. describe an effort to evolve far-red fluorescent proteins with excitation and 
emission spectra compatible with intravital imaging2.  The starting point for this evolution was 
mKate, a red fluoresecent protein with an available X-ray crystal structure4.  The authors relied 
heavily on this structural information to design a very small starting library (theoretical 
complexity of 4e2) with saturation at two residues proximal to the chromophore.  This library 
was easily interrogated in a simple plate-based screen to yield a single mutant with improved 
brightness and photostability.  From this output, a subsequent library design was guided by 
previous experience with other red-shifted fluorescent proteins, and a modest library (theoretical 
complexity 1.6e5) with saturation at four positions was screened.  An additional two rounds of 
random mutagenesis and screening yielded mNeptune, a superior red-shifted fluorescent protein 
that is four mutations away from the parent.  Here, the approach made use of prior information 
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Figure 1.1. Top. The canonical directed evolution cycle.  
Bottom left.  Scheme for discovery of far-red shifted fluorescent 
proteins (adapted from Lin et. al.2, plate image from Tsien Lab).  
Bottom right.  Scheme for discovery of more active 
transpeptidases (adapted from Liu and coworkers3).
and experience to guide the design of sequential small, high quality libraries that could be easily 
interrogated with a simple screen.  This success was achieved with remarkable economy.
A more complex challenge was addressed in evolving sortase A variants with improved 
transpeptidation activity3.  Here, the crystal structure of sortase A was also known5, but a wealth 
of experience and informed intuition was not available to guide the library design for this new 
evolution target.  Thus, the authors chose a large, randomly mutagenized library (complexity 
7.8e7) that could not be interrogated with a simple low through-put screen like that used in the 
previous example.  Instead, the authors crafted a selection in which displayed enzymes with high 
activity would self-label their host cells, allowing them to pass a FACS-based selection.  Since 
the library recovered after sorting was an enriched mixture, rather than discretely chosen 
individual clones, several rounds of sorting were required to bring the population to a high 
abundance of active clones that could be randomly chosen and analyzed.  After four rounds of 
sorting the output mixture showed some convergence, thus providing key information on 
possible determinants of improved activity; this information was absent during the initial library 
design.  With this understanding, a second library was generated by in vitro homologous 
recombination of the post-selection mixture, with a bias toward incorporation of the convergent 
mutations found in the first rounds.  Sorting of this library yielded dramatically improved clones 
that combined these early mutations.  Here, prospective guidance on initial library design was 
lacking, thus requiring a selection strategy with sufficient power to resolve active variants from a 
large, randomized library.  A subsequent, informed library of high quality was then screened to 
quickly arrive at active variants.
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It is obvious, but worth stating, that the potential success of such efforts is directly related 
to the probability that unknown hypothetical constructs with optimal or improved activity will be 
physically created and interrogated.  Several measures can be taken to favor success.  First, the 
quality of the library can be improved by using informed design decisions to increase the fraction 
of library members likely to have the desired activity6.  Second, the capacity of the screen or 
selection can be increased so that a larger library can be interrogated in a single round.  Finally, 
the efficiency of the overall protocol can be improved so that more iterations of mutation and 
selection can be performed in a reasonable timeframe, thus increasing the total number of 
variants explored.  This last improvement allows for the interrogation of advanced libraries that 
are launched from the improvements gained in earlier rounds; this search strategy can be very 
efficient if fit variants can be accessed by a reasonably smooth uphill path (a critical, and often 
untestable assumption)7.  For outstanding challenges in protein evolution, it is possible that large 
libraries, with many rounds of selection, will be required.
Methodological advances have already made it possible to discover useful biomolecules  
- thermostable cellulases8, site-selective DNA binding domains9, novel biosynthetic enzymes10, 
to name a few - within months to years.  Though there is obvious benefit to improving the 
efficiency of this (or any) discovery process, a drastic acceleration might also make it possible to 
address demands for which the current timescale is a more fundamental barrier; customized 
research reagents and patient-tailored therapeutics are two hypothetical applications with time-
sensitive prompts.  To satisfy these demands would require transformative methodological 
advances in directed evolution.
5
This thesis describes the development of a general platform for greatly accelerated in 
vivo directed evolution (Chapter 2), the addition of drift (Chapter 3) and negative selection 
(Chapter 4) capabilities to this platform, and the use of these advances (Chapter 5) to invert the 
specificity of an RNA polymerase in a single evolutionary trajectory of less than three days.
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Chapter Two
A System for the Continuous Directed Evolution of Biomolecules
Jacob Charles Carlson, Kevin M. Esvelt, David R. Liu
The continuous evolution system was co-developed by Kevin Esvelt and Jacob Carlson.  Kevin 
Esvelt performed the T7 RNA polymerase evolution experiments described here, and designed 
the initial PACE apparatus.
This chapter is adapted from published work in Nature, 472, 499-503 (2011)
2.1 Introduction
The canonical directed evolution protocol iterates mutagenesis, selection, and 
amplification until the researcher meets the desired endpoint or a practical time constraint.  A 
typical experimental cycle requires error prone PCR of a starting gene, insertion of the gene 
library into an expression vector context, transformation of that library into an expression host, 
treatment of the host to effect selection, amplification of those survivors, recovery of the DNA, 
and re-entry to diversification.  Notably, many of these steps are simple but time consuming 
DNA manipulations (Figure 2.1). 
A typical virus uses self and host machinery to rapidly execute DNA manipulations; the 
virus injects its encoding information into a new host cell, is amplified, and then recovers its 
genetic information back into the environment for transfer to a new host.  Note that many of the 
tedious steps in the directed evolution cycle have analogs in the viral life cycle (Figure 2.1).
Husimi and coworkers recognized the potential of a bacteriophage and host cell system to 
perform continuous evolution experiments1.  They designed an apparatus to automate the 
selection of bacteriophages through a constantly renewed population of host cells.  Briefly, a 
population of host cells, maintained in a “turbidostat’, was flowed at a constant rate into a 
“cellstat” that contained a population of M13 bacteriophage.  Phage infected newly added host 
cells, replicated, and new progeny were then secreted back into the medium where they infected 
more fresh host cells.  Husimi demonstrated that more fit M13 phage variants could experience 
rapid enrichment in this setup, even with small differences in replication rates2.  They even 
proposed the use of this system for applied molecular evolution experiments, but this goal went 
unrealized.
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2.2 Results and Discussion
2.2.1 Principle of a continuous evolution platform
 The efficiency of continuous bacteriophage selection can be harnessed for directed 
evolution by modifying key aspects of the viral life cycle.  First, enhanced mutagenesis during 
viral vector replication is required to constantly renew a diverse library.  Second, the autonomy 
of the native phage life cycle must be replaced with selection-dependent replication; the selection 
creates a link between the researcher-defined goal of the evolving, virus-borne gene and the 
replication rate of the encoding virus.
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Figure 2.1. Top. The cycle and timescale of conventional directed evolution. 
Bottom, the cycle and timescale of bacteriophage replication
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2.2.2 The life cycle of the filamentous bacteriophage
Our strategy for viral evolution utilizes the E. coli male-specific filamentous 
bacteriophage M133.  This phage does not kill its host cell upon release of progeny, it has no 
biphasic lytic/lysogenic lifestyle, and there are no firm limits on the minimal or maximal genome 
size that can be propagated4.  The M13 phage particle is a single-stranded DNA genome encased 
in a polymeric coat composed of thousands of monomers of the major coat protein pVIII, thus 
forming a filament (Figure 2.2).  At one end of the particle are an estimated five molecules each 
of the head cap proteins pVII and pIX, while the other end contains five molecules each of the 
tail cap proteins pVI and pIII5.  To initiate an infection, pIII binds first to the distal tip of E. coli 
conjugative F-pili6, which, through their normal dynamics of extension and retraction7, draw the 
bound phage to the periphery of the host cell where pIII again interacts with TolA8, the 
secondary receptor.  The particle is then uncoated as the genome is injected into the cytoplasm of 
the host cell, and its elegant developmental program begins.
The ssDNA phage DNA is engaged by host polymerases that synthesize the 
complementary strand9, thus creating a dsDNA that is the template for further replication, and a 
substrate for phage transcript synthesis. The genome is transcribed in two cascades10, one 
comprised of gII-X-V-VII-IX-VIII and the other of III-VI-I-XI-IV.  The locations of promoters, 
and rates of translation11 of resulting transcripts, are carefully balanced to afford the correct 
dynamics and stoichiometry of proteins required to assemble and compose the phage particle.  
pII, which is likely the first phage protein synthesized, nicks the dsDNA template within the 
replication origin12, thus allowing host polymerases to synthesize a new positive strand by rolling 
circle replication.  This positive strand can serve as either the template for a new round of 
11
complementary strand synthesis, or can be escorted to the cell membrane to be packaged into a 
progeny phage particle.  This decision is regulated by a simple developmental circuit composed 
of pII, pX, and pV13.  Early in the replication cycle, pII is abundant and promotes the re-entry of 
newly synthesized positive strands into the DNA replication cycle by excluding strand access by 
pV.  The concentration of dsDNA (the transcription template) increases and all phage proteins 
become more abundant.  At this stage, pV begins to downregulate expression of pII by binding 
site specifically to a structure in the translation initiation region of the gII 5’ UTR, reducing de 
novo pII synthesis14.  As a result, pV outcompetes pII for access to new positive strands, and 
newly synthesized strands are coated in pV for escort to the membrane.  Here, phage particle 
synthesis is coincident with export; the ssDNA genome is adorned with its protein coat as it is 
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Figure 2.2. Left. Structure of the filamentous phage particle.  Right. Genome 
organization of M13.
extruded.  This process is catalyzed by the morphogenetic proteins pI, pXI, and pIV15, 16, which 
together form an assembly site and extrusion pore that connects to the extracellular medium via a 
gated channel.  Head cap proteins pVII and pIX are added, and the length of the ssDNA sheds a 
coat of pV in exchange for the major coat protein pVIII5.  As the extruded particle reaches unit 
length, pVI and pIII are added to the tail cap of the particle, and pIII catalyzes excision of the 
particle from the membrane17, thus releasing the progeny.
2.2.3 Selection-dependent phage replication
This phage life cycle can be made selection-dependent by removing an essential gene 
from the phage genome, thus decoupling its expression from the native program.  The evolving 
gene can be encoded on the phage vector in place of this essential gene, which is instead borne 
on a host vector under selection-dependent expression control.  Many robust schemes exist that 
link potential target activities (DNA binding, protein binding, various enzyme activities, etc.) to 
gene expression18, thus establishing the crucial connection between phage replication and the 
activity of interest.
Each phage protein is essential to the replicative program, so in principle it is possible to 
use any of these genes to form the basis for a selection.  However, the phage can be 
deconstructed in multiple ways, which lead to different requirements for the choice of selection 
gene (Figure 2.3).  The selection phage system is conceptually the simplest.  The evolving gene 
replaces any essential gene on the native phage genome, and this gene is encoded on an 
accessory plasmid (AP) to be carried by the host cells.  Thus, host cells, prior to infection, 
contain only a single phage gene that is then activated by the evolving gene carried by the phage; 
13
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Figure 2.3. Left. A selection phagemid based system deconstructs the M13 genome 
into three parts.  Right.  A selection phage based system deconstructs the genome into 
two parts.
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this selection phage also carries in the remaining essential genes to build the progeny particles.  
In the selection phagemid system, an additional dissection is introduced by constitutively 
expressing the remaining phage genes from a helper plasmid (HP) carried by the host cells.  In 
this format, only the evolving gene is passaged on the phagemid vector, and all phage genes are 
present in the host cell prior to infection (with one under selection dependent control on the AP).  
Here, it is again possible to choose any essential gene to form the basis of the selection, but there 
is an additional requirement: if any of the phage proteins render host cells resistant to infection, 
they must be unexpressed prior to infection.  pIII is well known to render cells resistant to 
infection19, so gIII would have to be the basis for the selection in the phagemid format.  If placed 
under activity-dependent expression control, this gIII would remain off prior to infection and 
could then be stimulated in an activity dependent way by the evolving gene product carried on 
the phagemid.
 The phagemid format was the first one tested.  A “helper plasmid” (HP) was constructed 
in which all phage genes except gIII were encoded on a p15a-origin plasmid (does not include 
the phage replication origin).  gIII was then encoded on an “accessory plasmid” (AP) in which 
gIII transcript synthesis would be controlled by an activity-dependent promoter.  Finally, the 
evolving gene was encoded on a “selection phagemid” (SPm) that also contained the phage 
replication origin.  When combined in a single cell, these plasmids together express all the phage 
proteins required to assemble the phagemid, which uniquely contains the phage origin and 
packaging signal, into a phage particle (assuming that the SPm-encoded gene can activate 
expression from the AP).  Indeed, in mock experiments, this format was very capable of 
producing infectious phagemids with the expected dependence on gIII expression.  However, 
15
continuous experiments failed to yield robust propagation.  Indeed, even a positive control 
phagemid, which directly encoded gIII, could not be robustly propagated, suggesting either that 
phagemid production in continuous culture did not correspond to that observed in discrete 
experiments, or that host cells were not capable of receiving phagemid via infection.
 Using a new assay for host-cell competence, the helper plasmid was identified as a source 
of infection-resistance in host cells (Figure 2.4).  This observation conflicted with previous lab 
experience, and a published report of a helper plasmid used in phage display20.  pIII is widely 
known to render cells resistant to infection by causing membrane destabilization and F-pilus 
retraction19, but was not encoded on the helper plasmid, suggesting the influence of another 
phage protein.  pV was identified as a second source of infection resistance, an observation that 
is also supported by literature precedent21.  The mechanism is different from that caused by pIII 
(retraction of F-pili through TolA-mediated pleiotropic effects).  In the native phage life cycle, 
pV coats newly synthesized positive ssDNA strands and escorts them to the membrane for 
export.  Here, when pV is present prior to an infection, the newly infecting strand is subject to a 
cell fate decision: either host polymerases reach the ssDNA and initiate complementary strand 
synthesis, or pV reaches the strand first and escorts it back out for export (though the export 
would be “incomplete” since pIII would not be present).  The tuning of pII expression from the 
HP was used to partially rescue this defect13 and allowed propagation of phagemids, but it was 
clear that a selection phage-based system would still be more robust.
 This finding motivated the transition to the phage-based system; pIII would remain the 
basis for the selection and all other phage proteins (including pV) would be introduced by 
infection with the evolving phage.
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2.2.4 Implementation of PACE system
In phage-assisted continuous evolution (PACE), E. coli host cells continuously flow 
through a fixed-volume vessel (the “lagoon”) containing a replicating population of phage DNA 
vectors (“selection phage”, SP) encoding the gene(s) of interest.  The average residence time of 
host cells in the lagoon is less than the time required for E. coli replication. As a result, mutations 
accumulate only in the evolving SP population, the only DNA that can replicate faster than the 
rate of lagoon dilution. The mutation of host cells in the lagoon should therefore have minimal 
17
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Figure 2.4. Top. Interplay between pV and pII in controlling phage DNA replication. 
Bottom.  Recipient cells carrying HP are less infectable than empty cells.  Cells were 
incubated with phagemids encoding YFP and then plated.  The fraction of yellow colonies 
(which received the phagemid by infection) reports on the infectability of the original 
recipient culure.
impact on the outcome of the selection over many rounds of phage replication, and mutagenesis 
conditions are not limited to those that preserve E. coli viability.
Due to the speed of the phage life cycle (progeny phage production begins ~10 minutes 
post-infection)22, PACE can mediate many generations of selective phage replication in a single 
day. We observed activity-dependent phage vectors that tolerate lagoon flow rates up to 3.2 
volumes per hour, corresponding to ~115 population doublings and an average of ~38 phage 
generations per 24 hours.  More conservative flow rates of 2.0-2.5 volumes per hour allow 24-30 
generations per day and reduce the risk of complete phage loss (washout) during selections. 
Multiple lagoons can evolve genes in parallel, with each 100 mL lagoon containing ~5 x 1010 
host cells selectively replicating active phage variants. Importantly, PACE requires no 
intervention during evolution and obviates the need to create DNA libraries, transform cells, 
extract genes, or perform DNA cloning steps during each round. 
2.2.5 Enhanced mutagenesis
We constructed an arabinose-inducible mutagenesis plasmid (MP) that elevates the error 
rate during DNA replication in the lagoon by suppressing proofreading and enhancing error-
prone lesion bypass23, 24. Full induction increased the observed mutagenesis rate by ~100-fold 
(Figure 2.5), inducing all possible transitions and transversions. This enhanced mutation rate is 
sufficient to sample all possible single and double mutants of a given sequence each generation, 
in principle enabling single-mutation fitness valleys to be traversed during PACE.
The basal mutation rate of replicating filamentous phage (5.3x10–7 substitutions/bp) is 
sufficient to generate all possible single but not double mutants of a given library member in a 
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100 mL lagoon. For a target gene 1,000 base-pairs in length, a basal mutation rate of 5x10-7 
yields 2.5x107 base substitutions spread over 5x1010 copies of the gene in a 100 mL lagoon after 
one phage generation, easily covering all single point mutants but not all double mutants. 
Arabinose induction of the MP can increase the mutation rate to ~5x10-5, yielding ~2.5x109 
mutations spread over 5x1010 copies of the gene after one generation. The vast majority are 
single mutants which together comprise a target area of ~2.5x1012 base pairs, suggesting that 
some 1.2x108 are double mutants, sufficient to cover all 9x106 possible double mutants.
2.2.6 Evolution of T3 promoter recognition by T7 RNA polymerase
Bacteriophage T7 RNA polymerase (T7 RNAP) is widely used to transcribe RNA in vitro 
and in cells. T7 RNAP is highly specific for its promoter sequence (TAATACGACTCACTATA), 
19
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Figure 2.5. A mutagenesis plasmid (MP) increases the mutation rate in a lagoon by up 
to ~100-fold.  Phage bearing lacI were propagated with and without arabinose and used 
to infect a reporter strain that expresses spectR under lacI control.  Colonies indicate 
infection with phage carrying mutated lacI.
and exhibits virtually no detectable activity on the consensus promoter of the related 
bacteriophage T3 (AATTAACCCTCACTAAA, differences underlined)25, 26. Despite decades of 
study and several attempts to engineer the specificity of T7 RNAP towards other promoters27 
including that of T3, a mutant T7 RNAP capable of recognizing the T3 promoter has not been 
previously reported. 
To remove potential interference from evolutionary improvements to the phage vector 
rather than to T7 RNAP, we propagated an SP expressing wild-type T7 RNAP for three days on 
host cells containing an AP with the wild-type T7 promoter driving gIII expression. A single 
plaque presumed to represent vector-optimized SP contained a single mutation (P314T) in T7 
RNAP. We confirmed that the activity of the P314T mutant does not significantly differ from that 
of wild-type T7 RNAP.
This starting SP failed to propagate on host cells containing the T3 promoter AP. We 
therefore propagated the phage on cells containing a hybrid T7/T3 promoter AP with the T7 
promoter base at the important -11 position25 but all other positions changed to their T3 
counterparts. Two initially identical lagoons were evolved in parallel on the hybrid promoter AP 
for 60 hours, then on the complete T3 promoter AP for 48 hours, and finally on a high-
stringency, very low-copy T3 promoter AP for 84 hours(Figure 2.6).
In both lagoons phage persisted after 8 days of PACE, surviving a net dilution of 10167 
fold, the equivalent of 555 phage population doublings and ~200 rounds of evolution by the 
average phage. We isolated, sequenced, and characterized phage vectors from each lagoon after 
48, 108, and 192 hours, observing up to eight, ten, and 11 non-silent mutations in single T7 
RNAP genes at each time point.
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Protein-encoding regions (without upstream promoter sequences) of evolved mutant T7 
RNAP genes were subcloned into assay plasmids that quantitatively link transcriptional activity 
to beta-galactosidase expression in cells28. We defined the activity of wild-type T7 RNAP on the 
T7 promoter to be 100%. The starting T7 RNAP exhibited undetectable (< 3%) levels of activity 
on the T3 promoter in these cell-based assays. The assayed mutants exhibited > 200% activity 
after 108 hours of PACE, and > 600% activity following high-stringency PACE at 192 hours, 
improvements of more than 200-fold (Figure 2.7). These results collectively establish the ability 
of PACE to very rapidly evolve large changes in enzyme activity and specificity with minimal 
intervention by the researcher. 
Several evolved T7 RNAP mutants were also purified and assayed in vitro using 
radioactive nucleotide incorporation assays. Purified T7 RNAP mutants exhibited activity levels 
21
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Figure 2.6. Schedule for evolution of T7 RNAP mutants that can recognize the T3 
promoter.
on the T3 promoter in vitro exceeding that of wild-type T7 RNAP on the T7 promoter, 
representing improvements of up to 89-fold compared with the starting enzyme. These results 
indicate that PACE resulted in large improvements in substrate binding or catalytic rate. Evolved 
activity improvements were higher in cells than in vitro, suggesting that these enzymes also 
evolved improvements in features such as expression level, polymerase folding, or stability that 
are specific to the context of the cytoplasm. 
2.3 Materials and Methods
2.3.1 General Materials and Methods
All DNA cloning was performed with Mach1 cells or NEB Turbo cells. Early discrete 
infection assays and PACE experiments were performed with PirPlus DH10βF'DOT cells. Plaque 
assays and PACE experiments with T7 RNAP were performed with using E. coli S109 cells 
derived from DH10B by replacement of the proBA locus with the pir116 allele, as previously 
described29.  This modification enables R6K based phagemids to replicate in recipient cells, 
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Figure 2.7. In vitro activity of evolved RNAP clones
which is needed for some infectability assays.  Similarly, the lacI cassette was deleted from the F 
plasmid and from the chromosome to enable mutagenesis assays. The modified F plasmid 
derives from E. coli ER2738 (NEB) The complete genotype of the resulting strain is F´proA+B+ 
Δ(lacIZY) zzf::Tn10(TetR)/ endA1 recA1 galE15 galK16 nupG rpsLΔlacIZYA araD139 
Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC) proBA::pir116 λ-.
Discrete (non-continuous) infectivity assays were performed by co-transforming phage 
bearing antibiotic resistance genes with the appropriate accessory plasmid into competent cells to 
generate phage donors.  Colonies were picked and grown overnight in 2xYT media with both 
antibiotics. 2 µL donor cells were mixed with 198 µL F+ recipient cells in mid-exponential phase 
containing an antibiotic resistance gene not found in the donor. Mixtures were incubated at 37 °C 
for 1.5 hours and 20 µL of serial dilutions were spread on plates containing the donor and the 
recipient antibiotics. Infection was quantified by the number of resulting colonies after 
incubation at 37 °C overnight. For plaque assays, phage DNA was transformed into 
electrocompetent cells containing the appropriate accessory plasmid and recovered for 1 hr at 37 
°C, or simply isolated from a lagoon. Serial dilutions were mixed with 300 µL F+ recipient cells 
grown to exponential phase in 14 mL Falcon culture tubes and incubated at 37°C for 15 minutes. 
3 mL top agar (7 g/L from LB broth base) at 50 °C was added to each tube, briefly vortexed, and 
poured onto minimal agar plates incubated at 37 °C for 8 hours or overnight to generate 
plaques. 
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2.3.2 Assay for infection-competence of recipient cells
 Recipient cultures were grown to mid-log phase, and 100 µL of culture was mixed by 
pipetting with 2 µL of pJC126b phagemid prep (encodes R6K origin, f1 origin, pLac-YFP) 
totaling ~1e9 cfu.  Reactions were incubated for 2 minutes and then stopped by transfer of 1 µL 
to 1 mL of fresh 2xYT media.  Cells were pelleted, resuspended in 1 mL fresh 2xYT, and an 
aliquot was diluted 10-fold into fresh media.  20 uL was plated to 2xYT-agar plates with 1 mM 
IPTG and grown overnight.  Colonies were scanned on a Typhoon laser imager (488 nm laser, 
520/40 filter).
2.3.3 Turbidostat and lagoon setup and operation
Turbidostats were constructed from BioProbe flasks on magnetic stir plates. Each flask 
was equipped with a TruCell2 cell density meter held in a GL32 probe holder with compression 
fitting. GL45 and GL32 septa pierced with needles transferred media to and from the turbidostat 
via an 8-channel peristaltic pump with Tygon tubing. A needle set at the desired turbidostat 
volume level pumped excess cells to the waste container. A 0.2 µm filter attached to a 14-gauge 
needle piercing the septum vented the turbidostat vessel. A two-way valve controlled media flow 
to the turbidostat, connected such that a closed valve state returned the media to source. The 
valve opened and closed in response to TruCell2 4-20 mA output processed by a digital panel 
meter programmed with the desired set point. Panel meters were unlocked according to the 
instruction manual and programmed to the following settings:  Input dc_A, Setup 30_ 10, Config 
00000, Filtr 11009, dec.pt ddd.dd, lo in 00.400, lo rd 004.00, hi in 02.000, hi rd 020.00, Alset 
00036, deu1h 000.01, deu2h 000.01. The digital panel meter, adapter, and valve were connected 
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with a solderless breadboard according to the diagram shown in Supplementary Fig. 12. Lagoons 
consisted of 100 mL Pyrex bottles with GL45 septa pierced with needles for fluid delivery, a 0.2 
µm filter-terminated vent line, and a magnetic stir bar. Excess lagoon volume was continually 
pumped to waste via a waste needle set at the desired lagoon volume.
Each 20 L media carboy received 140 g anhydrous potassium phosphate dibasic, 40 g 
potassium phosphate monobasic, 20 g ammonium sulphate, and 20 mL Tween 80 in 20 L H2O. 
Carboys were loosely capped with Polyvent filling/venting closures with an autoclavable 0.2 µm 
filter fastened to the venting port. Media was autoclaved until visibly boiling (typically 120 min 
at 30 psi, 121 °C) and allowed to cool overnight. Media supplement was prepared from 90 g 
glucose, 10 g sodium citrate, 0.25 g anhydrous magnesium sulphate, 10 g casamino acids, 0.15 g 
tetracycline-HCl, 0.6 g carbenicillin, 0.6 g spectinomycin, and 0.5 g (L)-leucine, dissolved in 500 
mL H2O, and filtered with a Nalgene 500 mL filtration unit. 500 mL media supplement was 
added to each carboy under conditions that minimize the risk of media contamination (in the case 
of the reported experiments, immediately following 1 hour of germicidal UV irradiation).
The autoclavable components of a turbidostat apparatus include the BioProbe flask, 
TruCell2 probe, needles, vent filter, and tubing. All such components were autoclaved fully 
assembled except for tubing, which was connected while hot. Upon equilibrating to ambient 
temperature, the peristaltic pump responsible for media addition and waste removal was started 
with the valve opened until the desired volume was reached. The TruCell2 probe was connected 
to its transmitter and zeroed. Turbidostats were seeded with 100 µL of an overnight culture of 
host cells. Turbidostats and lagoon cultures were grown at 37 °C. 
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Serial dilution plating was used to generate a calibration curve to determine TruCell2 
output and panel meter setting corresponding to the desired cell density. For these experiments, 
both panel meter alarms were programmed to open the valve at 6.80 mA. Cells were pumped 
from the turbidostat to the lagoons via peristaltic pumps with silicone (platinum) two-stop 
tubing. Calibration curves relating pump speed in rpm to volumetric flow rate were determined 
experimentally with a timer and graduated cylinder for each tubing size. 
2.3.4 PACE experiments
Turbidostats and lagoons were assembled as described above. Upon the turbidostat 
reaching the desired set point of 6.80 mA (corresponding to 5 x 108 cells/mL in our hands), 
lagoons were connected to turbidostats, waste needles were set at the desired volume, and lagoon 
pumps were set to a flow rate corresponding to the desired dilution rate. Each lagoon was seeded 
with 100 µL of an overnight culture producing selection phage. To induced elevated 
mutagenesis, 10% filter-sterilized (L)-arabinose was delivered by a separate peristaltic pump to 
each lagoon requiring enhanced mutagenesis to a final concentration of 1%. Lagoon aliquots 
were taken by sampling lagoon waste lines at the luer lock just after the peristaltic pump. 
Individual clones were isolated by plaque assay or amplified by PCR, assembled into a T7 
RNAP activity assay plasmid, and transformed into cells containing a lacZ reporter plasmid. 
Active clones were picked by blue/white screening.
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2.3.5 Selection phage optimization. 
T7 RNAP was subcloned into VCSM13 helper phage encoding kanamycin resistance, 
generating HP-T7RNAP A. To ensure that improvements to the phage genome did not interfere 
with the evolution of T7 RNAP, HP-T7RNAP A was propagated in a lagoon fed by S109 host 
cells containing AP-T7 A and DP-QUR and supplemented with arabinose for 72 hours at 2.0 
volumes/hour. Individual plaques were isolated and their T7 RNAP genes sequenced. One plaque 
contained only a single point mutation in T7 RNAP, P314T, and was chosen as the preoptimized 
selection phage for T7 RNAP evolution. Sequencing of the rest of the selection phage revealed 
numerous changes relative to the parental VCSM13. Notably, the entire p15a-KanR cassette 
inserted into the intergenic (IG) region to create VCSM13 had been perfectly deleted to 
reconstitute the wild-type M13 IG region. Other changes included N79S, F286S, and I360T 
mutations in gIV, a K249R mutation in gII, three silent mutations back to the corresponding M13 
base, two other silent mutations, and the deletion of one thymine residue in the terminator before 
gIII, possibly increasing the expression of T7 RNAP. These regional patterns of variation parallel 
those observed by Husimi in more extensive filamentous phage evolution experiments. This 
evolved phage, designated SP-T7RNAP P314T, was used as the starting selection phage for all 
subsequent PACE experiments.
2.3.6 Mutagenesis assays
The lacI gene was cloned into VCSM13 between the p15a origin and kanr to generate 
VCSM13-lacI. A turbidostat was grown to a set point equivalent to 5x108 cells/mL with S109 
cells containing the mutagenesis plasmid (MP). Lagoons were seeded with 10 µL VCSM13-lacI 
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and run at 2.5 volumes/hour for 3 hours. One lagoon was supplemented with 10% arabinose to a 
final concentration of 1%,  while the other was not. Aliquots were removed after 3 hours and 
each was used to infect a 100-fold greater volume of recipient cell culture of S109 cells 
containing a reporter plasmid conferring carbenicillin and spectinomycin resistance with a lacI 
binding site (lacO) capable of repressing spectinomycin resistance. Mixtures were incubated for 
1.5 hr at 37°C, spread on 2xYT plates containing spectinomycin, kanamycin, and carbenicillin, 
and incubated at 37°C overnight. Colonies were counted for induced and uninduced lagoons to 
estimate the fold increase in mutagenesis. 72 colonies were sequenced to determine the 
frequencies of all transitions and transversions within mutated lacI genes.  All sequenced 
colonies contained at least one mutation capable of inactivating repressor function.
2.3.7 Cell-based T7 RNAP activity assays
Overnight cultures of S109 cells grown in 2xYT containing reporter plasmid and 
expression vector were diluted 4-fold in fresh 2xYT media. 20 µL of the diluted culture was 
mixed with 80 µL Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 
mM beta-mercaptoethanol, pH 7.0) in Falcon Microtest 96-well OptiLux assay plates and the 
absorbance at 595 nm was measured using a Spectra M5 plate reader. 25 µL of 1 mg/mL 
methylumbelliferyl-beta-(D)-galactopyranoside was added to each well and the time recorded. 
Plates were incubated at 30 °C and fluorescence was measured at 360/460nm on a Spectra M5 
plate reader. Plates were measured at multiple time points to avoid saturation of the 
spectrophotometer or consumption of the substrate, depending on the activity level of the T7 
RNAP enzyme being assayed. MUG fluorescence units were calculated as previously described. 
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The activity level of wild-type T7 RNAP on the T7 promoter was defined as 100%; activities > 
3% were considered significantly above the background level of this assay.
2.3.8 T7 RNAP protein purification
T7 RNAP variants were cloned into pT7-911Q, a His-tagged T7 RNAP expression vector. 
Overnight cultures grown at 30°C were diluted 1:500 in LB broth containing 50 µg/mL 
carbenicillin and 2% glucose. Upon reaching OD600 = ~0.5, cultures were centrifuged at 4000 g 
for 5 minutes and resuspended in LB broth with 0.4 mM IPTG and 50 µg/mL carbenicillin. 
Cultures were grown for 4 hours at 30°C, spun at 8000 g for 6 minutes, and the pellet was frozen 
overnight. Binding buffer consisted of 50 mM Tris, 300 mM NaCl, 5% glycerol, 5 mM beta-
mercaptoethanol, and 10 mM imidazole at pH 8.0. Wash buffer consisted of 50 mM Tris, 800 
mM NaCl, 5% glycerol, 5 mM beta-mercaptoethanol, and 20 mM imidazole at pH 8.0. Elution 
buffer was equivalent to wash buffer with 500 mM imidazole. Pellets from 25 mL culture were 
resuspended in 1 mL wash buffer and cells were lysed by sonication while kept on ice using a 
Misonix CL4 sonicator at maximal microtip power for 45 seconds in 1-second bursts. Cell debris 
was spun down at 20,000 g for 15 minutes at 4°C. Ni-NTA spin columns were equilibrated with 
500 µL binding buffer and spun at 800 g for 2 minutes. Lysate supernatant was loaded onto each 
column and spun at 300 g for 5 minutes. Columns were washed twice with 500 µL wash buffer, 
spinning at 800 g for each, then eluted twice with 250 µL elution buffer. Proteins were dialyzed 
into 20 mM Tris, 100 mM NaCl, 5% glycerol, 1 mM EDTA, 1 mM DTT, pH 8.0, and 
concentrated using Amicon Ultra-0.5 30K concentration columns. 
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2.3.9 In vitro T7 RNAP activity assays
Purified T7 RNAP variant concentrations were determined by Bradford assay and then by 
Coomassie stain on a 4-12% NuPage gel. Templates were prepared by PCR amplification of 150 
bp fragments of the reporter plasmids used for in vivo assays including the promoter and the start  
of the lacZ gene. Templates were purified by MinElute spin column. Transcription reactions were 
performed in 1x RNA polymerase buffer consisting of 40 mM Tris-HCl, 6 mM MgCl2, 10 mM 
dithiothreitol, 2 mM spermidine pH 7.9 with 1 mM rNTPs, 1 ng template DNA, purified 
polymerase variant, and 2 mCi [α-32P]ATP. Reactions were incubated at 37 °C for 20 minutes, 
mixed with an equivalent volume of loading dye consisting of 7 M urea, 178 mM Tris-Cl, 178 
mM H3BO3, 4 mM EDTA and 0.002% bromophenol blue, then electrophoresed on Criterion 5% 
or 10% TBE-urea denaturing gels. RNAs were transcribed from double-stranded templates of 
sequence 
5’-TAATACGACTCACTATAGGGAGAGCCACCACCACCACCACCACCA-3’, 
5’- TAATACGACTCACTATACCCCCCGCCACCACCACCACCACCACCA -3’, and 5’- 
TAATACGACTCACTATAAAAAAAGCCACCACCACCACCACCACCA -3’ (the +1 base is 
underlined in bold).  Transcripts were electrophoresed on Criterion 15% TBE-urea gels, exposed 
to phosphor screens, and imaged on a Typhoon Trio phosphorimager. Bands corresponding to 
transcription products were quantified with ImageJ software.
30
2.4 References
1. Husimi, Y. Selection and evolution of bacteriophages in cellstat. Adv. Biophys. 25, 1-43 
(1989).
2. Husimi, Y., Nishigaki, K., Kinoshita, Y. & Tanaka, T. Cellstat-a continuous culture system 
of a bacteriophage for the study of the mutation rate and the selection process of the 
DNA level. Rev. Sci. Instrum. 53, 517-522 (1982).
3. Salivar, W.O., Tzagoloff, H. & Pratt, D. Some physical-chemical and biological 
properties of the rod-shaped coliphage M13. Virology 24, 359-371 (1964).
4. Lopez, J. & Webster, R. E. Morphogenesis of filamentous bacteriophage f1: orientation of 
extrusion and production of polyphage. Virology 127, 177-193 (1983).
5. Endemann, H. & Model, P. Location of filamentous phage minor coat proteins in phage 
and in infected cells. J. Mol. Biol. 250, 496-506 (1995).
6. Jacobson, A. Role of F pili in the penetration of bacteriophage fl. J. Virol. 10, 835-843 
(1972).
7. Clarke, M., Maddera, L., Harris, R. L. & Silverman, P. M. F-pili dynamics by live-cell 
imaging. Proc. Natl. Acad. Sci. U. S. A. 105, 17978-17981 (2008).
8. Riechmann, L. & Holliger, P. The C-terminal domain of TolA is the coreceptor for 
filamentous phage infection of E. coli. Cell 90, 351-360 (1997).
9 Geider, K. & Kornberg, A. Conversion of the M13 viral single strand to the double-
stranded replicative forms by purified proteins. J. Biol. Chem. 249, 3999-4005 (1974).
10. Edens, L., Konings, R. N. & Schoenmakers, J. G. A cascade mechanism of transcription 
in bacteriophage M13 DNA. Virology 86, 354-367 (1978). 
11. Blumer, K. J., Ivey, M. R. & Steege, D. A. Translational control of phage f1 gene 
expression by differential activities of the gene V, VII, IX and VIII initiation sites. J. Mol. 
Biol. 197, 439-451 (1987).
 
12. Dotto, G. P., Horiuchi, K. & Zinder, N. D. Initiation and termination of phage f1 plus-
strand synthesis. Proc. Natl. Acad. Sci. U. S. A. 79, 7122-7126 (1982).
 
13. Fulford, W. & Model, P. Bacteriophage f1 DNA replication genes. II. The roles of gene V 
protein and gene II protein in complementary strand synthesis. J. Mol. Biol. 203, 39-48 
(1988).
31
14. Model, P., McGill, C., Mazur, B. & Fulford, W. D. The replication of bacteriophage f1: 
gene V protein regulates the synthesis of gene II protein. Cell 29, 329-335 (1982).
15. Haigh, N. G. & Webster, R. E. The pI and pXI assembly proteins serve separate and 
essential roles in filamentous phage assembly. J. Mol. Biol. 293, 1017-1027 (1999).
16. Linderoth, N. A., Model, P. & Russel, M. Essential role of a sodium dodecyl sulfate-
resistant protein IV multimer in assembly-export of filamentous phage. J. Bacteriol. 178, 
1962-1970 (1996).
17. Rakonjac, J. & Model, P. Roles of pIII in filamentous phage assembly. J. Mol. Biol. 282, 
25-41 (1998).
18. Vidal, M. & Legrain, P. Yeast forward and reverse n-hybrid systems. Nucleic Acids Res. 
27, 919-929 (1999).
19. Boeke, J. D., Model, P. & Zinder, N. D. Effects of bacteriophage f1 gene III protein on 
the host cell membrane. Mol. Gen. Genet. 186, 185-192 (1982).
20. Chasteen, L., Ayriss, J., Pavlik, P. & Bradbury, A. R. M. Eliminating helper phage from 
phage display. Nucleic Acids Res. 34, e145 (2006).
21. Terwilliger, T. C., Fulford, W. D. & Zabin, H. B. A genetic selection for temperature-
sensitive variants of the gene V protein of bacteriophage f1. Nucleic Acids Res. 16, 
9027-9039 (1988).
22. Calendar, R. The Bacteriophages (Oxford Univ. Press, 2006)
23. Fijalkowska, I. J. & Schaaper, R. M. Mutants in the Exo I motif of Escherichia coli dnaQ: 
defective proofreading and inviability due to error catastrophe. Proc. Natl. Acad. Sci. U. 
S. A. 93, 2856-2861 (1996).
24. Opperman, T., Murli, S., Smith, B. T. & Walker, G. C. A model for a umuDC-dependent 
prokaryotic DNA damage checkpoint. Proc. Natl. Acad. Sci. U. S. A. 96, 9218-9223 
(1999).
25. Raskin, C. A., Diaz, G., Joho, K. & McAllister, W. T. Substitution of a single 
bacteriophage T3 residue in bacteriophage T7 RNA polymerase at position 748 results in 
a switch in promoter specificity. J. Mol. Biol. 228, 506-515 (1992).
26. Ikeda, R. A., Chang, L. L. & Warshamana, G. S. Selection and characterization of a 
mutant T7 RNA polymerase that recognizes an expanded range of T7 promoter-like 
sequences. Biochemistry 32, 9115-9124 (1993).
32
27. Raskin, C. A., Diaz, G. A. & McAllister, W. T. T7 RNA polymerase mutants with altered 
promoter specificities. Proc. Natl. Acad. Sci. U. S. A. 90, 3147-3151 (1993).
28. Vidal-Aroca, F. et al. One-step high-throughput assay for quantitative detection of beta-
galactosidase activity in intact gram-negative bacteria, yeast, and mammalian cells. 
BioTechniques 40, 433-434, 436, 438 passim (2006).
29. Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97, 6640-6645 
(2000).
33
Chapter Three
A Method for Stringency Modulation in Continuous Evolution
Jacob Charles Carlson, Drago Guggiana Nilo, David R. Liu
Drago Guggiana Nilo built the real-time luminescence monitor.  Jacob Carlson designed and 
performed all other experiments.
3.1 Introduction
We previously used PACE to evolve T7 RNA polymerase mutants that initiate 
transcription at the T3 promoter, which differs from the T7 promoter at 6 of 17 base 
positions.  We first challenged the wild-type enzyme to evolve activity directly on the T3 
promoter, but this attempt failed, suggesting that the stringency of this initial selection 
was too high.  We then designed a hybrid T7/T3 promoter to serve as a lower-stringency 
evolutionary stepping stone, and from the library evolved on this hybrid promoter the 
transition to recognition of the full T3 promoter was realized.  Fortunately, our hybrid 
promoter design was guided by extensive literature knowledge of the sequence 
determinants of T7 and T3 promoter recognition1.  However, we recognize that for many 
potential applications of PACE, the choice of suitable intermediate substrates may not be 
intuitive or informed by literature precedent.  Therefore, such a strategy lacks immediate 
generality and may limit the extent to which a protein activity can be practically altered.  
To address this limitation, we designed a generic modulator of stringency that can be 
engaged and tuned with the simple addition of a small molecule, and that operates 
irrespective of the activity being evolved.  Using this advance, we demonstrate that T3-
active polymerases can be rapidly evolved from the T7-specific wild-type enzyme 
without the use of intermediate substrates.
Technical advances in the use of a chemostat grown recipient cell culture, and a 
real-time monitor of luminescence, were used in this and subsequent chapters and are 
described here.
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3.2 Results and Discussion
3.2.1 Development of chemostat culture and real-time monitor
 Previous continuous evolution experiments made use of a turbidostat to maintain 
a regular culture of recipient cells.  This setup is expensive and prone to technical 
difficulty, so a chemostat culture system was implemented.  Cells grown in chemostat 
culture are at high density, which exacerbates problems with cell clumping and clogging 
of tubes.  Disruption of biofilm genes (as described in Materials and Methods) resolved 
issues with clumping.
  The ability of chemostat grown cells to support propagation was found to be 
growth rate dependent.  At chemostat dilution rates  of ~1.6 vol/hr, propagation of a 
positive control SP-T7 on cells bearing a pT7-gIII cassette was robust (Figure 3.1).
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Figure 3.1. Demonstration of chemostat and real-time monitor with propagation of an SP-
T7 phage.  Upper left, Tracking of phage titer over time using chemostat grown cells.  
Upper right,  Setup of chemostat.  Lower left, Real-time luminescence monitoring of 
lagoon.  Lower right, Setup of real-time monitor.
 A real-time monitor of phage propagation was implemented by constructing a 
device for the in-line measurement of lagoon cell luminesence deriving from a coupled 
gIII-luciferase reporter.  The details of construction are described in Materials and 
Methods.  Luminescence signal was found to correlate strongly with the titer of a positive 
control phage (Figure 3.1)
3.2.2 Development of Small Molecule Controlled Drift Capability
To create a system for tunable selection stringency, we built upon existing 
strategies for small-molecule controlled gene expression.  The TetR repressor of Tn10 
represses promoters by binding to cognate operators at positions that occlude RNA 
polymerase or transcription factor binding2.  This repression is relieved by addition of 
tetracycline and its more potent analogs (e.g. anhydrotetracycline, ATc)3.  We constructed 
an AP with gIII downstream of a modified pTetA promoter (containing an additional TetR 
operator) and demonstrated ATc-dependent gene expression and phage production 
(Figure 3.2), but found that this AP did not support robust phage propagation in a PACE 
format when ATc was added to a lagoon (Figure 3.2).  Phage were amplified very slowly, 
implying that the overall replication rate was near the limit of the dilution rate.
We hypothesized that the problem was related to the infectability of the cells.  It is 
known that low levels of pIII-expression will result in retraction of F-pili (the primary 
receptor for phage infection), thus rendering cells resistant to infection4.  We speculated 
that our recipient cells, which begin expressing pIII immediately upon entering an ATc 
induced lagoon, were becoming phage-resistant prior to an initial infection and hindering 
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propagation.  In discrete tests, recipient cells carrying induced pTet-gIII do not support 
activity independent plaque formation with SP-T7 or wild type phage, and are not 
competent in an explicit infection assay (Figure 3.3).  Though these discrete tests cannot 
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Figure 3.2. Top. Architecture of pTet, psp, and psp-tet candidates.  Middle left.  Luciferase 
gene expression measurements of candidate drift cassettes in the presence and absence of ATc 
and IPTG (which induces pIV expression from a separate pLac-pIV cassette).  Middle right.  
Phage production from discrete cultures in the presence and absence of ATc.  Bottom.  
Continuous propagation of phage with indicated drift cassettes.
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capture the more dynamic induction that would occur with recipient cells entering a 
lagoon, it is likely that the same phenomenon is obstructive to continuous propagation.  
Robust drift might be achieved by including an explicit requirement for phage infection 
prior to induction.
To create a system in which activity-independent gIII expression requires both 
ATc and a prior phage infection, we took advantage of previous studies of the E. coli 
phage shock promoter (psp)5.  This promoter is induced by a number of environmental 
signals, including infection by filamentous phage.  Induction proceeds via expression of 
phage protein pIV, which inserts into the inner membrane, thereby initiating a signaling 
cascade that results in the binding of the transcriptional activator PspF to the phage shock 
promoter6.  Thus, any phage that encodes pIV will induce this promoter in infected cells, 
and it has previously been shown that a phage deleted of gIII will form plaques on cells 
bearing a psp-gIII cassette7.  We prepared cells with an AP carrying a psp-gIII cassette 
and observed pIV-dependent gene expression and robust phage production.  Since psp has 
some basal expression of pIII, a mild defect with recipient cell infection is expected, and 
indeed observed in discrete assays (Figure 3.3).  However, the defect does not seriously 
compromise activity-independent plaque formation (Figure 3.3) and continuous 
propagation (Figure 3.2).
We expected that induction from psp could be made ATc dependent by careful 
placement of TetR operators within critical regions of the promoter.  Regulation of this 
promoter is known to be complex, so several variants were explored with TetR operators 
at candidate positions intended to disrupt either PspF or RNA polymerase binding (Figure 
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Figure 3.3. Top. Plaque assay with drift cassettes.  Middle.  Discrete infection assay using 
YFP-encoding phagemids.  Bottom.  Test of mutagenesis strength for drift-modified MPs 
as inferred by arabinose induced cell killing. pJC184 is the original MP, pJC184d5 
combines mutagenesis and drift cassettes on a single plasmid, and pJC184d-Sp/184 harbors 
drift and mutagenesis cassettes on separate plasmids.  All are compatible with simultaneous 
use of standard accessory plasmids.
3.2).  We found that operators placed adjacent to binding sites for RNA polymerase, but 
not PspF, could effectively regulation psp induction.  Placement of a TetR operator 
adjacent to the +1 transcription initiation site (in pJC175h) creates a promoter (herein 
referred to as psp-tet) that is maximally induced by the combination of ATc and pIV (as a 
surrogate for phage infection) and supports ATc dependent phage production (Figure 3.2). 
This drift cassette also performed well in discrete tests for plaque formation and infection 
competence (Figure 3.3).  When an AP with this psp-tet-gIII cassette was tested in a 
PACE format, phage propagation was found to be robust and ATc dependent, thus making 
it possible to propagate a library with no starting activity (Figure 3-2).
3.2.3 The Stringency of a Selection Can Be Tuned With ATc
We next examined how the psp-tet-gIII cassette would influence the enrichment 
of active library members over inactive library members in the context of an actual PACE 
selection, in which an additional copy of gIII is controlled by an activity-dependent 
promoter.  At intermediate concentrations of ATc, a phage encoding a new, active library 
member should enjoy a replicative advantage by inducing additional pIII expression from 
an activity-dependent promoter.  This advantage should be inversely proportional to the 
concentration of ATc provided; as ATc induced pIII approaches saturating concentrations, 
the additional benefit of activity-induced pIII expression diminishes, as does the selection 
for active library members.  Knowledge of this relationship is essential to maximize the 
speed with which an active library member can be generated and enriched.
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To test the effect of psp-tet-gIII on activity-dependent enrichment, we moved this 
cassette onto a modified mutagenesis plasmid (pJC184d5) that can be used in conjunction 
with an activity dependent AP and verified ATc-dependent phage production (Figure 3.2), 
plaque formation, and discrete infection competence (Figure 3.3).  We also examined the 
mutagenesis properties of this modified MP (as assayed by cell death upon arabinose 
induction) and found a weaker response suggestive of a reduced mutagenesis rate.  The  
problem could be resolved by maintaining the drift and mutagenesis cassettes on two 
separate, compatible plasmids (pJC184d-Sp, pJC184, respectively), which preserved ATc-
dependent phage production (Figure 3.2) and full induced mutagenesis (Figure 3.3), but 
the combined MP (pJC184d5) was used and found suitable for most experiments.  
We set up lagoons with recipient cells containing both this modified MP and an 
AP with the T7 promoter driving gIII expression (Figure 3.4).  Lagoons were seeded with 
a mixture of phage encoding an inactive T7 RNAP (SP-mut, active site mutation 
D812G)8 and the WT T7 RNAP in a ratio of 100:1, induced with varying concentrations 
of ATc, and the phage concentrations were observed over time.  As expected, without 
ATc, SP-T7 was rapidly enriched over the SP-mut.  At an intermediate concentration of 
ATc (150 ng/mL), SP-T7 still enriched but at a slower rate.  At the highest ATc 
concentration (400 ng/mL), enrichment of SP-T7 was not observed, suggesting that 
neutral selection had been achieved.  When ATc was then withheld from this lagoon, SP-
T7 rapidly enriched as expected.  Taken together, these experiments show that psp-tet-
gIII supports the propagation of inactive starting libraries while still allowing the 
selective enrichment of active mutants.
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Figure 3.4. Top. Plasmids used in continuous drift experiment. Bottom left. Tracking of 
phage ratios over time by restriction digest.  Bottom right. In-line luminescence monitoring 
of lagoons; high luminesence indicates an enrichment of the active SP-T7 phage.
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3.3 Materials and Methods
3.3.1 General Materials and Methods
 For all experiments in this chapter, the bacterial host strain is DH10B S1030.  All 
continuous flow experiments are performed using recipient cells grown in a chemostat 
using the custom Davis rich media formulation.  Discrete cultures are also grown in this 
same Davis rich media formulation, except where noted.  All cultures were grown with 
antibiotic supplementation for the maintenance of exogenous plasmids (when a plasmid 
with the corresponding resistance gene was present) in the following concentrations: 
ampicillin (50 µg/mL), spectinomycin (50 µg/mL), chloramphenicol (40 µg/mL).  
Streptomycin (for selection of DH10B cells carrying the rpsL marker) and tetracycline 
(for selection of F plasmid) were not routinely included in culture media.  Test strains 
were prepared by transformation of electrocompetent DH10B S1030 with appropriate 
plasmids, and plating on 2xYT agar supplemented with appropriate antibiotics.
      For discrete experiments, 2 mL seed cultures were grown in 14 mL culture tubes.  
Cultures for gene expression measurements were typically grown as 0.5 mL volumes in 
96-well deep well plates (Axygen, #391-01-061) seeded with a 0.2-1.0% inoculum of 
overnight culture.
3.3.2 Chemostat growth conditions and demonstration
 Media for chemostat growth was prepared by autoclaving a 20 L carboy of MilliQ water 
containing: K2HPO4 anhydrous (140 g), KH2PO4 (40 g), (NH4)2SO4 (20 g), NaCl (58 g), 
casamino acids (100 g), Tween (20 mL), L-cysteine (1 g), L-tryptophan (0.5 g), adenine (0.5 g), 
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guanine (0.5 g), cytosine (0.5 g), uracil (0.5 g), CaCl2 (0.5 µM) final.  This was allowed to cool, 
and amended with a 500 mL filter-sterilized solution of MilliQ water containing: NaHCO3 (16.8 
g), glucose (90 g), sodium citrate (10 g), MgSO4 (1 g), FeSO4 (56 mg), thiamine (134 mg), 
calcium pantothenate (94 mg), para-aminobenzoic acid (54 mg), para-hydroxybenzoic acid (54 
mg), 2, 3 dihydroxybenzoic acid (62 mg), (NH4)6Mo7 (3 nM final), H3BO3 (400 nM final), cobalt 
acetate (30 nM), CuSO4 (10 nM final), MnCl2 (80 nM final), ZnSO4 (10 nM final).
 For demonstration of chemostat based phage propagation, SP-T7 (1e7 pfu) was 
inoculated into a 60 mL lagoon (flow rate 2 vol/hr) that was receiving chemostat grown cells 
harboring an AP with pT7-gIII-luxAB.  The chemostat dilution rate was ~1.6 vol/hr.
3.3.3 Construction and operation of real-time luminescence monitor
 The in-line bioluminescence measurements were taken by a custom-built online 
luminometer. A TD-20e luminometer (Turner Designs) was installed inside a dark box in 
continuous reading mode. While in this mode, the luminometer outputs a DC voltage that varies 
between 0 and 4 V depending on the light level received by the photomultiplier fitted in the 
instrument (the range was set to the most sensitive one). This signal was sent to an Arduino 
Mega (Arduino) prototyping board through the analog input port. The Arduino board was 
controlled via Matlab (Mathworks), using a custom made Graphical User Interface (GUI). 
Measurements were taken at around 100 Hz and then integrated to 1 s before being written by 
the software into a text file.
  To allow for multichannel recordings, the system was fitted with a custom-built tube 
holder that could hold up to four flow-through tubes with minimal cross talk between channels 
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(below noise level). The holder allows for only one tube to be observed at a time, and it is 
mounted on a stepper motor that is in turn controlled using the Matlab GUI via the Arduino 
board and a Pololu A4988 stepper motor driver Pololu R&E) . The system waits until a 
measurement is complete before rotating the sample holder until the next tube is in position. 
From there it repeats the cycle until all channels are covered and then it unwinds to start a new 
cycle so that the tubes do not entangle.
 Matlab was the main tool used for data analysis. The purpose of the analysis is to extract 
the features of the luminescence fluctuation that are relevant to the timescale and purpose of the 
experiment, even when the time resolution of the instrument is much higher than that.  The code 
loads the data from the text files and separates it in the three channels used in the experiments. 
Then the data is binned by a factor of 10 to get rid of most of the artifacts due to the fast 
measurements. Following this we transform the data into "timeseries" format and filter it with an 
ideal notch filter. This removes all the high frequency information that is of no relevance to the 
analysis. After filtering the data is again binned by a factor of 10 to render a very smooth trace 
that provides the low frequency features.  Finally, the data is saved to an Excel spreadsheet that 
is used to generate plots.
3.3.4 Engineering of host strain
 Starting from commercial DH10B E. coli, the Lambda Red method9 was used to modify 
the genome as follows: 1) replace proBA with the pir-116 gene, enabling use of R6K origin 
plasmids and allowing proline auxotrophy to be used as a mechanism of F plasmid selection if 
needed, 2) delete lac IZYA, allowing use of LacI based mutagenesis screen, 3) create a scarless 
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mutation of rpoZ such that the start codon is mutated and a frameshift is introduced to the coding 
region.  The scarless strategy was necessary to avoid a toxic polar effect with spoT.  the mutation 
of rpoZ enables n-hybrid schemes that use a  fusion  to the N-terminus of the RNAP omega 
subunit (competition with endogenous omega subunit is problematic).
 Starting from commercial ER2738, the  Lambda Red method was used to modify the F 
plasmid as follows: 1) deletion of lacIZY, which allowed us of LacI based mutagenesis screens
2) integration of a cassette that overexpresses LacI and TetR, thus allowing the use of these 
inducible expression systems, 3) integration of a cassette that expresses luxCDE, which encode 
for enzymes in decanal biosynthesis.  this modification enables luciferase measurements to be 
taken easily and continuously without the addition of exogenous substrate.
 The modified F plasmid was mated into the modified DH10B strain to create S714.  This 
strain was used in initial chemostat experiments, and severe clumping of cells and clogging of 
tubing was observed.  The Lambda Red method was then used to delete: 1) the csg operon and 2) 
flu operon.
 This strain performed better in chemostat experiments, and clumping was not observed 
until after several days.  But, clumping became severe in this strain when any additional plasmid 
(apart from the AP) was included.  pgaC was then disrupted, and biofilm formation was 
substantially abolished under any conditions.  In addition to biofilm gene disruption, the AraE 
promoter was replaced with a constitutive promoter to enable titrable arabinose induction10, and 
also possibly increase the inducible mutagenesis rate by increasing the kinetics of arabinose 
induction.  Mating of this strain with the modified F plasmid yielded strain S1030.
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3.3.5 Assay for infection-competence of recipient cells
 Recipient cultures were grown to mid-log phase, and 100 µL of culture was mixed by 
pipetting with 2 µL of pJC126b phagemid prep (encodes R6K origin, f1 origin, pLac-YFP) 
totaling ~1e9 cfu.  Reactions were incubated for 2 minutes and then stopped by transfer of 1 µL 
to 1 mL of fresh 2xYT media.  Cells were pelleted, resuspended in 1 mL fresh 2xYT, and an 
aliquot was diluted 10-fold into fresh media.  20 uL was plated to 2xYT-agar plates with 1 mM 
IPTG and grown overnight.  Colonies were scanned on a Typhoon laser imager (488 nm laser, 
520/40 filter).
3.3.6 Discrete assay for phage production
 Cultures with candidate drift plasmids contained: pT7 (pJC173b), pTet 
(pJC148i2), psp (pJC175e), psp-tet (pJC175g/h/k/m/n), psp-tet on MP (pJC184d5), psp-
tet on colE1-spect plasmid (pJC184d-Sp).  Cultures were grown to mid-log phase, 
infected with an excess of SP-T7, and cells were pelleted and washed to remove residual 
excess phage.  Cells were re-inoculated into fresh media and grown to ~OD 0.8, and 
supernatants were saved for titering.  ODs were measured to normalize titers later.
3.3.7 Mutagenesis assay
 Arabinose induced cell killing is used as a surrogate for a functional mutagenesis 
plasmid.  Cells were grown to mid-log phase, serial dilutions were prepared and spotted 
on 2xYT agar plates with or without 5 mM arabinose.
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3.3.8 Test of pTet-p3 drift cassette in continuous flow experiment
 A chemostat culture of DH10B S1030 carrying plasmid pJC148i2 was prepared 
and growth was equilibrated overnight; the flow rate was 400 mL/hr in a chemostat 
volume of 250 mL.  The next morning, two lagoons (volume 40 mL, flow rate 100 mL/
hr) were started and seeded with 107 pfu of SP-T7.  Lagoons received supplements 
delivered by syringe pump (flow rate 1 mL/hr) consisting of either 20 µg/mL ATc (to 
make 200 ng/mL final concentration) or vehicle (H2O).  At 4 hr. intervals, 0.6 mL 
samples were taken from lagoons, measured discretely for luminescence, and centrifuged 
to remove cells.  Supernatants were combined with an equal volume of 50% glycerol and 
stored in the freezer.  Supernatants were later titered on cells of DH10B S1030 containing 
pJC173b (an AP carrying pT7-p3).
 
3.3.9 Test of psp-p3 drift cassette in continuous flow experiment
 A chemostat culture of DH10B S1030 carrying plasmid pJC175e was prepared 
and growth was equilibrated overnight; the flow rate was 400 mL/hr in a chemostat 
volume of 250 mL.  The next morning, a lagoon (volume 40 mL, flow rate 100 mL/hr) 
was started and seeded with 107 pfu of SP-T7.  At 4 hour intervals, 0.6 mL samples were 
taken from the lagoon, measured discretely for luminescence, and centrifuged to remove 
cells. Supernatants were combined with an equal volume of 50% glycerol and stored in 
the freezer.  Supernatants were later titered on cells of DH10B S1030 containing pJC173b 
(an AP carrying pT7-p3).
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3.3.10 Test of psp-tet-p3 drift cassette in continuous flow experiment
 A chemostat culture of DH10B S1030 carrying plasmid pJC175h was prepared 
and growth was equilibrated overnight; the flow rate was 400 mL/hr in a chemostat 
volume of 250 mL.  The next morning, two lagoons (volume 40 mL, flow rate 100 mL/
hr) were started and seeded with 107 pfu of SP-T7.  Lagoons received supplements 
delivered by syringe pump (flow rate 1 mL/hr) consisting of either 20 µg/mL ATc (to 
make 200 ng/mL final concentration) or vehicle (H2O).  At 4 hour intervals, 0.6 mL 
samples were taken from the lagoon, measured discretely for luminescence, and 
centrifuged to remove cells. Supernatants were combined with an equal volume of 50% 
glycerol and stored at in the freezer.  Supernatants were later titered on cells of DH10B 
S1030 containing pJC173b (an AP carrying pT7-p3).
3.3.11 Test of dose-dependent stringency tuning with drift cassette
A chemostat culture of DH10B S1030 carrying plasmids pJC184d5 and pJC173c 
was prepared and growth was equilibrated overnight; the flow rate was 400 mL/hr in a 
chemostat volume of 250 mL.  The next morning, three lagoons (volume 40 mL, flow 
rate 100 mL/hr) were started, with the waste lines diverted toward the in-line 
luminescence monitor.  Lagoons were seeded with a mixture containing 109 SP-T7-
D812G and 107 SP-T7, along with ATc in an amount that instantly brings the 40 mL 
lagoon to the final concentration supplied by syringe.  Lagoons received supplements 
delivered by syringe pump (flow rate 1 mL/hr) consisting of either 15 µg/mL ATc (to 
make 150 ng/mL final concentration), 40 µg/mL ATc (to make 400 ng/mL final 
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concentration), or vehicle (H2O).  At t = 8 hr, the lagoon receiving 40 µg/mL ATc was 
switched to receive vehicle.  At timepoints t = 2, 4, 6, 8, 16 h, 0.6 mL samples were taken 
from the lagoon, measured discretely for luminescence, and centrifuged to remove cells. 
Supernatants were combined with an equal volume of 50% glycerol and stored in the 
freezer.
Supernatants were analyzed for relative phage ratios using a PCR and analytical 
digest.  1 µL of each supernatant was added to a 20 µL Q-PCR reaction (iQ SYBR Green 
Mastermix, Biorad) with primers 1480/JC1481 and amplified by PCR with SYBR Green 
fluorescence monitored following each amplification cycle.  Samples were removed 
individually from the PCR block after crossing a pre-determined fluorescence threshold, 
and placed on ice.  Samples were then quantitated again by SYBR Green fluorescence in 
a plate reader, and approximately equal amounts of DNA from the reactions (normalized 
based on the fluorescence readings) were added to restriction digest reactions. The digest 
reactions used enzymes EcoRV and HindIII in buffer NEB2 with BSA, prepared 
according to manufacturer instructions in 20 µL total volumes.  Digestions were heat 
inactivated, combined with 0.2 volumes of 5X loading dye containing Orange G and 
xylene cyanol, and analyzed by agarose gel electrophoresis (1% agarose, 0.5X TBE, 
120V, 80 min).  The electrophoresed gel was stained with SYBR Gold (30 min, using 
manufacturer protocol, Invitrogen) and imaged on a Typhoon laser scanner (excitation 
488, emission 520/40 nm).
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Chapter Four
A Method for Negative Selection in Continuous Evolution
Jacob Charles Carlson, Ahmed H. Badran, David R. Liu
Jacob Carlson designed and performed all experiments, with the excellent assistance of Ahmed 
Badran.
4.1 Introduction
In our first PACE evolution experiments, the T3-active polymerases still retain their 
original high activity on the T7 promoter; these evolved enzymes are substrate 
promiscuous.  This result is not surprising, as we and others have observed that in the 
absence of explicit negative selection against undesired activity, the directed evolution of 
novel substrate recognition often results in enzymes with broadened, rather than truly 
altered specificity.  We envision that many targets of PACE (for example, proteases, 
protein binders, recombinases, etc) will require exceptional substrate selectivity to 
operate, with orthogonality, in the context of complex environments with many potential 
off-target substrates.  Motivated by this need for selectivity, we developed a general 
negative selection for PACE in which undesired activity (e.g. off-target substrate 
recognition) induces expression of pIII-neg, a competitive inhibitor of pIII-mediated 
infectious phage production.  This scheme operates in parallel, and simultaneously, with 
pIII-based positive selections to effect the rapid enrichment of highly active and 
substrate-specific mutants.  We demonstrate the power of this dual selection in a mock 
enrichment in which a substrate selective RNAP is selected out of a starting 1,000,000-
fold excess of a substrate promiscuous RNAP.
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4.2 Results and Discussion
4.2.1 Development of a PACE Compatible Negative Selection
A PACE compatible negative selection should link undesired or off-target activity 
to inhibition of infectious phage production, and would ideally have the following 
properties: (i) inhibition would be specific to phage production, and not influence host 
cell viability, (ii) the relationship between off-target activity and inhibition would be 
easily tuned, (iii) inhibition would be proportional to the ratio of on and off-target 
activity, rather that just the absolute level of off-target activity.  These criteria led us to 
consider a negative selection in which undesired activity induces expression of a variant 
of pIII that antagonizes the wild type pIII induced by a positive selection.  To this end, we 
searched for a mutant of pIII that inhibits phage production.  
The role of pIII in filamentous phage production is complex; it is essential for 
both the beginning and end of the phage life cycle.  The protein is comprised of three 
domains, N1, N2, and C that together mediate infection of a host cell through initial 
attachment to the F-pilus tip (N2 domain), subsequent docking with the TolA cell-surface 
receptor (N1 domain), and unlocking of the particle for genome entry (C domain)1,2,3.  
Following infection, new progeny are synthesized as the replicated phage genome is 
extruded out through the host cell membrane as a pVIII-coated ssDNA filament.  As 
synthesis of a unit length particle nears completion, pIII, which resides anchored by its C-
terminus to the periplasmic face of the inner membrane, is attached via it’s C-domain to 
the end of the particle in a stoichiometry of five molecules of pIII per particle.  A 
presumed conformational change in pIII then catalyzes excision from the inner 
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membrane and release of the particle from the host cell in a process thought to bear 
symmetry with the infection process described above3.  A wealth of biochemical and 
genetic experiments have defined regions of each domain essential for these steps, and 
these studies have raised a set of corresponding mutant proteins deficient in each process.  
One mutant described in this literature, termed N1-N2-C83, was of particular interest3.
N1-N2-C83 contains in-tact N1 and N2 domains but has an internal deletion of 70 
residues within the C domain.  The residual C-domain contains sufficient information to 
mediate attachment to (but not catalyze excision of) a phage particle.  When co-expressed 
with a pIII variant comprised of only the intact C-domain (which can mediate particle 
release), phage particle production was found to be normal, but the infectivity of these 
particles was drastically reduced.  The phage particles, which contained a mixture of N-
C83 and intact C-domains, were deficient in a step of the infection process following 
initial cell surface attachment.  The authors described a model in which infection was 
obstructed because a particular in cis relationship between N1, N2, and full length C of 
the same pIII molecule is required to mediate the unlocking of a particle.  However, we 
considered an alternative explanation, in which N1-N2-C83 might obstruct the cascade of 
conformational changes otherwise transmitted through all the in-tact C domains.  If the 
latter model were true, this variant should also function as a dominant negative of full 
length, wild type pIII.
To test N-C83 expression as a candidate negative selection scheme, we created a 
host cell line containing a gIII deleted phage (SP-T7), an AP with a pTet-gIII cassette 
(induced by ATc) and a second accessory plasmid (termed AP-neg) with a pLac-N1-N2-
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C83 cassette (induced by IPTG).  Discrete production cultures were grown at two 
concentrations of ATc, and with or without IPTG, and culture broths were assayed for 
infectious phage titer.  The addition of IPTG, which induces N1-N2-C83 expression, 
dramatically reduced the titer of infectious phage.  The fold change in infectious phage 
production was dependent on the concentration of ATc added.  At 4 ng/mL ATc, a 20-fold 
decrease was observed, while at 20 ng/mL ATc, a 5-fold decrease was observed when 
IPTG was included (Figure 4.1).  Alternative pIII-neg candidates, which included the full 
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Figure 4.1. Effect on phage production of pIII-neg candidate expression. 
Constructs from left to right are 156a2 (C-domain), 156c2 (C83), 156j2 
(N1-N2-C83), 156m2 (N2-C83), 156o2 (N1*-N2-C83)
C-domain, or C83 (which contains the 83 residues of the C-domain present in N1-N2-
C83) had no effect on infectious phage production when expressed.  Variants of N1-N2-
C83 were also created with deletions of either the N1 domain or the YGT residues that 
causes F-pilus retraction and resistance to infection; these variants were found to be 
inhibitory to phage production, but the magnitude of the effect was reduced.
  The dose dependence was verified by preparing recipient cells with pT7-gIII and 
pT3-ribo-N1-N2-C83 and observing phage production in the presence and absence of 
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Figure 4.2 Dose dependent effect of pIII-neg expression on phage production of the 
promiscuous phage SP-192.2 or specific phage SP-48.3.  SP-192.2 produces fewer 
progeny phage only when theophylline is added.  The total secreted DNA was also 
measured and found to be reduced accordingly.
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theophylline (Figure 4.2).  Only promiscuous phage SP-192.2 is hindered by theophylline 
addition.  Interestingly, the amount of secreted phage DNA in these cultures was also 
measured, and found to be reduced by an amount that explains the reduced infectious 
titer.  This suggests that pIII-neg may inhibit infectious phage production by blocking the 
excision of extruding phage progeny, rather than influencing the infectivity of the 
resulting particles.  This observation contradicts the original model.  Nonetheless, these 
results demonstrate that expression of N1-N2-C83, herein referred to as pIII-neg, can 
form the basis of a very potent negative selection that is ratio-dependent with respect to 
pIII.
4.2.2 Demonstration of negative selection with continuous mock enrichment
 Having determined that pIII-neg expression can reduce infectious phage 
production in discretely grown cultures, we next determined if, in a mock PACE 
experiment, this negative selection could be used to enrich for a substrate specific T7 
RNAP over a promiscuous one.  For this competition experiment, we cloned SPs 
encoding either of two RNAP variants from our previous study: L2-48.3 (specific for T7 
promoter, SP-48.3) and L1-192.2 (promiscuous for T7 and T3 promoters, SP-192.2).  We 
then prepared host cells containing an AP with the T7 promoter driving pIII expression, 
and an AP-neg with the T3 promoter driving pIII-neg transcription with pIII-neg 
translation controlled by a theophylline-activated riboswitch4.  In these host cells, a phage 
encoding a promiscuous, T3-active RNAP should be penalized with pIII-neg expression, 
and only when theophylline is provided.  Three lagoons containing these host cells were 
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Figure 4.3. Mock enrichment of a pT7-selective RNAP (SP 48.3) over a pT7/pT3 
promiscuous RNAP (SP-192.2).  Recipient cells contained an AP with pT7-gene III-luxAB 
and an AP-neg with pT3-pIII- neg (top).  A ratio of 1,000,000:1 SP-192.2:SP-48.3 was seeded 
into lagoons.  At t = 0 hr, the indicated theophylline treatments were applied.  Time points 
were taken and phage samples were analyzed by PCR and restriction digest to asses the 
relative abundance of the two phage species (left).  Lagoons were also monitored with a real-
time, in-line luminescence reader that reports population activity on the T7 promoter (right).
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each seeded with a 106:1 ratio of SP-192.2:SP-48.3 and allowed to equilibrate for 4.5 
hours.  We then treated the lagoons with three different concentrations of theophylline (0, 
75, 1000 uM) and followed the concentrations of the two SP species over time.  We 
observed that, in the presence of theophylline, the promiscuous phage was rapidly 
depleted from the lagoon and replaced by SP-48.3 (Figure 4.3).  This result demonstrates 
that p3-neg, serving as a potent and dose dependent negative selection, can effect the 
rapid enrichment of substrate selective RNAPs.
4.3 Materials and Methods
4.3.1 General Materials and Methods
 For all experiments in this chapter, the bacterial host strain is DH10B S1030 and 
the chemostat media and growth conditions are those described in Chapter 3.  Discrete 
cultures are grown in the Davis rich media formulation (Chapter 3), except where noted.  
All cultures were grown with antibiotic supplementation for the maintenance of 
exogenous plasmids (when a plasmid with the corresponding resistance gene was 
present) in the following concentrations: ampicillin (50 µg/mL), spectinomycin (50 µg/
mL), chloramphenicol (40 µg/mL).  Streptomycin (for selection of DH10B cells carrying 
the rpsL marker) and tetracycline (for selection of F plasmid) were not routinely included 
in culture media.  Test strains were prepared by transformation of electrocompetent 
DH10B S1030 with appropriate plasmids, and plating on 2xYT agar supplemented with 
appropriate antibiotics.
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      For discrete experiments, 2 mL seed cultures were grown in 14 mL culture tubes.  
Cultures for gene expression measurements were typically grown as 0.5 mL volumes in 
96-well deep well plates (Axygen, #391-01-061) seeded with a 0.2-1.0% inoculum of 
overnight culture.
 
4.3.2 Test of pIII-neg candidates
 A host strain of DH10B S1030 containing pJC148i2 and either pJC156a2 (C-
domain), pJC156c2 (C83), pJC156j2 (N1-N2-C83), pJC156m2 (N2-C83), or pJC156o2 
(N1*-N2-C83) was prepared and grown to mid-log phase in Davis rich media.  Cells 
were then infected with an excess of SP-T7, incubated  in the warm room for 10 min, 
spun down and washed to remove residual phage, and resuspended in fresh 2xYT media.  
These infected cells were then used as inocolum for discrete 2xYT cultures grown in 
either ATc 4ng/mL or 20 ng/mL and in the presence or absence of 2 mM IPTG.  Cultures 
were grown to OD ~0.9, cells were removed by centrifugation, and the supernatants were 
titered by plaque assay on DH10B S1030 cells carrying a pT7-AP.
4.3.3 Test of dose-dependent negative selection in discrete experiments
 A host strain of DH10B S1030 containing pJC173c and pJC174c-R5 was 
prepared and grown to mid-log phase in Davis rich media.  Cells were then infected with 
an excess of either SP-T7 192.2 or SP-T7 48.3, incubated in the warm room for 10 min, 
spun down and washed to remove residual phage, and resuspended in fresh Davis rich 
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media.  These infected cells were then used as inocolum for discrete Davis rich media 
cultures grown with the indicated concentrations of theophylline.  
4.3.4 Test of dose-dependent negative selection in continuous flow experiments
A chemostat culture of DH10B S1030 carrying plasmids pJC173c and pJC174c-
R5 was prepared and growth was equilibrated overnight; the flow rate was 400 mL/hr in 
a chemostat volume of 250 mL.  The next morning, three lagoons (volume 40 mL, flow 
rate 100 mL/hr) were started, with the waste lines diverted toward the in-line 
luminescence monitor.  Lagoons were seeded with a mixture containing 1010 SP-192.2D 
and 104 SP-48.3 and allowed to equilibrate for 4.5 hrs; during this time the lagoons 
received 0.1 M NaOH at 0.5 mL/hr by syringe pump.  After equilibration (t = 0 hr), 
lagoons received supplements delivered by syringe pump (flow rate 0.5 mL/hr) consisting 
of either 200 mM theophylline (to make 1 mM final concentration), 15 mM theophylline 
(to make 75 µM final concentration), or vehicle (0.1 M NaOH).  After 16 hrs, the lagoon 
receiving vehicle was switched to receive 200 mM theophylline (1 mM final 
concentration).  At timepoints t = 0, 2, 4, 6, 8, 10, 12, and 20 h, 0.6 mL samples were 
taken from the lagoon, measured discretely for luminescence, and centrifuged to remove 
cells. Supernatants were combined with an equal volume of 50% glycerol and stored in 
the freezer.
Supernatants were analyzed for relative phage ratios using a PCR and analytical 
digest.  1 µL of each supernatant was added to a 20 uL Q-PCR reaction (iQ SYBR Green 
Mastermix, Biorad) with primers JC1163/JC1488 and amplified by PCR with SYBR 
Green fluorescence monitored following each amplification cycle.  Samples were 
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removed individually from the PCR block after crossing a pre-determined fluorescence 
threshold, and placed on ice.  Samples were then quantitated again by SYBR Green 
fluorescence in a plate reader, and approximately equal amounts of DNA from the 
reactions (normalized based on the fluorescence readings) were added to restriction 
digest reactions.  The digest reactions used AvaII in buffer NEB4, prepared according to 
manufacturer instructions in 20 µL total volumes.  Digestions were combined with 0.2 
volumes of 5X loading dye containing Orange G and xylene cyanol, and analyzed by 
agarose gel electrophoresis (1% agarose, 0.5X TBE, 120V, 80 min).  The electrophoresed 
gel was stained with SYBR Gold (using manufacturer protocol, Invitrogen) and imaged 
on a Typhoon laser scanner (excitation 488, emission 520/40 nm).
64
4.4 References
1. Rakonjac, J. & Model, P. Roles of pIII in filamentous phage assembly. J. Mol. Biol. 282, 
25-41 (1998).
2. Rakonjac, J., Feng, J. n. & Model, P. Filamentous phage are released from the bacterial 
membrane by a two-step mechanism involving a short C-terminal fragment of pIII. J. 
Mol. Biol. 289, 1253-1265 (1999).
3. Bennett, N. J. & Rakonjac, J. Unlocking of the filamentous bacteriophage virion during 
infection is mediated by the C domain of pIII. J. Mol. Biol. 356, 266-273 (2006).
4. Lynch, S. A. & Gallivan, J. P. A flow cytometry-based screen for synthetic riboswitches. 
Nucleic Acids Res. 37, 184-192 (2009).
65
Chapter Five
Evolution of T7 RNA Polymerases with Specificity for the T3 Promoter
Jacob Charles Carlson, David R. Liu
Jacob Carlson designed and performed all experiments.
5.1 Introduction
To demonstrate the utility of the advances in Chapters 3 and 4, we integrated both 
developments by continuously evolving mutant T7 RNA polymerase enzymes with 
greatly altered substrate specificities in a single PACE experiment.  The evolved enzymes 
exhibit selectivity for their target substrate that exceeds that of native phage RNA 
polymerases for their cognate substrates, while also maintaining wild-type-like levels of 
activity.
5.2 Results and Discussion
5.2.1 Evolution of T3-selective RNAPs from WT T7 RNAP 
Our approach for evolving RNAPs with altered specificities is depicted in Figure 
5.1.  We divided the task into a series of stages designed to first acquire activity on the T3 
promoter, and then gradually eliminate remaining activity on the T7 promoter.  The 
expectation was that as we increased the stringency of the positive selection (by reducing 
pIII expression per unit activity), activity on the T3 promoter would increase.  As we 
increased the stringency of the negative selection (increasing pIII-neg expression per unit 
activity), activity on the T7 promoter would decrease (Figure 5-1).  
We began by preparing two lagoons with host cells containing a pT3-gIII AP and 
the modified MP encoding the psp-tet-gIII cassette, and seeded these lagoons with SP-T7, 
which has negligible starting activity on pT3.  To one lagoon, we added no ATc and 
observed that phage quickly washed out, as expected.  To the second lagoon, we added 
200 ng/mL ATc, which was previously observed to allow inactive phage to propagate by 
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minimizing the selection stringency.  After 12 hours (t = 12 hr), phage were present, but 
still encoded RNAPs with negligible activity on pT3.  We then reduced the concentration 
of ATc to 20 ng/mL, thus increasing the selection stringency relative to the starting 
condition. 
 After six hours (t = 18 hr), the in-line luminescence monitor showed a clear 
increase in signal (Figure 5-1), suggesting that a T3-active population had overtaken the 
lagoon.  This signal continued to increase, and RNAPs isolated from a later timepoint (t = 
28 hrs) showed a ~100-fold increase in activity on pT3 and converged on two mutations, 
E222K and N748D, that have been observed by us and others to broaden the substrate 
scope of T7 RNAP (Figure 5-2)1,2. This result demonstrates that tunable selection 
stringency can be used to directly evolve a novel activity from inactive starting libraries 
without the use of intermediate substrates as evolutionary stepping stones.
 As expected, the RNAPs recovered from this stage of the selection were 
promiscuous and retained high activity on pT7.  To initiate the negative selection against 
recognition of pT7, we prepared host cells containing the same pT3-gIII AP, the MP 
(lacking the drift cassette), and a pT7-gIII-neg AP-neg with pIII-neg expression 
controlled by a theophylline dependent riboswitch3.  The lagoon from the drift stage was 
then switched to receive these recipient cells and the lagoon was allowed to equilibrate 
for four hours, after which theophylline was added to trigger the counterselection (t = 32 
hrs).  After 24 hours at this intermediate stringency stage (t = 52 hrs), many of the 
RNAPs isolated had acquired a modest improvement in selectivity for pT3 (Figure 5.2) 
and these improved clones contained a variety of mutations proximal to the promoter 
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(R96L, K98F, E207K, P759L).  In contrast, clones isolated from the no-theophylline 
lagoon did not show such changes in activity.
 To further enhance the selectivity of our evolving RNAPs, we increased the 
stringency of the negative selection in two ways.  First, we weakened the ribosome 
binding site driving translation of pIII from the AP, with the expectation that evolved 
RNAPs would compensate with increased (but pT3-selective) transcriptional activity.  
Second, we modified the AP-neg to contain a high copy pUC origin, and replaced the 
theophylline riboswitch with a very strong ribosome binding site driving pIII-neg 
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Figure 5.1. In-line luminescence monitoring (top), stringency schedule (middle), and constructs 
(bottom) used to evolve T3-selective enzymes starting from WT T7.
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Figure 5.2. Activity and mutations present in clones isolated following the drift stage (left, t = 
28 hrs), low stringency counterselection without theophylline (center left, t= 52 hrs), low 
stringency counterselection with theophylline (center right, t=52 hrs), and high stringency 
counterselection (right, t = 70.5 hrs).  Mutations in blue are conserved in all clones and are 
found to confer activity on pT3.  Mutations in red are conserved in high specificity clones.  
Mutations in purple are, as a group, conserved and physically clustered, but mutually exclusive 
of each other.  Mutations in gray and black are isolated, and mildly conserved, respectively.
translation.  Together, these modifications should increase the stringency of the 
counterselection by increasing the ratio of pIII-neg to pIII for a given ratio of activity on 
pT7:pT3.  The phage population from the previous stage was then changed to receive 
these host cells, and the luminescence monitor indicated a dramatic decline and rebound 
of the population.  RNAPs isolated following this recovery (t = 70 hrs) had dramatically 
improved specificity and had converged completely on promoter proximal mutations 
R96L, K98R, P759S/L (Figure 5.2).
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Figure 5.3. Forward mutation analysis of convergent changes.  Changes in blue contribute to 
promiscuous activity on pT3, and changes in red contribute to selectivity for pT3 over pT7.
5.2.2 Dissection of specificity conferring mutations
 A forward mutation study was performed (Figure 5.3) to examine the contribution 
of convergent mutations to the specificity of the final clones.  The double mutation of 
E222K/N748D was found to be essential for acquiring activity on the T3 promoter, and 
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Figure 5.4. Convergent mutations in T7 RNAP-promoter complex4.  Blue spheres are T7 
promoter substrate, light blue spheres show changes between the T7 and T3 promoters.  Cyan 
spheres are residues enabling pT3 recognition, red spheres contribute to selective pT3 
recognition, purple spheres are a conserved cluster of exclusive mutations seen in final clones.
the R96L, K98R, and P759L mutations conferred high specificity toward T3 (and against 
T7).
5.3 Materials and Methods
5.3.1 General Materials and Methods
 For all experiments in this chapter, the bacterial host strain is DH10B S1030 and 
the chemostat media and growth conditions are those described in Chapter 3.  Discrete 
cultures are grown in the Davis rich media formulation (Chapter 3), except where noted.  
All cultures were grown with antibiotic supplementation for the maintenance of 
exogenous plasmids (when a plasmid with the corresponding resistance gene was 
present) in the following concentrations: ampicillin (50 µg/mL), spectinomycin (50 µg/
mL), chloramphenicol (40 µg/mL).  Streptomycin (for selection of DH10B cells carrying 
the rpsL marker) and tetracycline (for selection of F plasmid) were not routinely included 
in culture media.  Test strains were prepared by transformation of electrocompetent 
DH10B S1030 with appropriate plasmids, and plating on 2xYT agar supplemented with 
appropriate antibiotics.
      For discrete experiments, 2 mL seed cultures were grown in 14 mL culture tubes.  
Cultures for gene expression measurements were typically grown as 0.5 mL volumes in 
96-well deep well plates (Axygen, #391-01-061) seeded with a 0.2-1.0% inoculum of 
overnight culture.
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5.3.2 Evolution of T3 selective RNA polymerases
 A chemostat culture of DH10B S1030 carrying plasmids pJC184d5 and pJC174f 
was prepared and growth was equilibrated overnight; the flow rate was 400 mL/hr in a 
chemostat volume of 250 mL.  The next morning, two lagoons (volume 50 mL, flow rate 
100 mL/hr) were started, with the waste lines diverted toward the in-line luminescence 
monitor.  Lagoons were seeded with 105 pfu of SP-T7.  Lagoons received supplements 
delivered by syringe pump (flow rate 1 mL/hr) consisting of either 20 µM ATc for 
Lagoon 1 or vehicle (500 mM L-arabinose) for Lagoon 2.  At t = 12 hrs, Lagoon 1 was 
switched to receive 2 µM ATc.  At t = 28 hrs, the first chemostat was discontinued and 
both lagoons began receiving cells from a second chemostat with DH10B cells containing 
plasmids pJC184, pJC174f, and pJC173f-R5 (prepared in the same way).  Both lagoons 
received arabinose.  At t = 32 hrs, half of Lagoon 1 was transferred to a new lagoon, 
Lagoon 3 and equilibrated for 40 min.  Lagoons 1 and 2 then received 100 mM 
theophylline (dissolved in 0.1 M NaOH, flow rate 1 mL/hr) and Lagoon 3 received 
vehicle.  At t = 52 hrs, the second chemostat was discontinued and all lagoons began 
receiving cells from a third chemostat with DH10B cells containing plasmids pJC184, 
pJC174k, and pJC173g-SD8 (prepared in the same way).  All lagoon volumes were 
reduced to 40 mL (flow rate maintained at 100 mL/hr) and were supplemented with 
arabinose.  At t = 70.5 hrs, lagoon volumes were reduced to 30 mL (flow rate maintained 
at 100 mL/hr).  Periodically, 0.6 mL samples were taken from the lagoon, measured 
discretely for luminescence, and centrifuged to remove cells. Supernatants were 
combined with an equal volume of 50% glycerol and stored in the freezer.
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5.3.3 Gene expression properties of evolved phage
 Cells for luminescence assays were DH10B S1030 containing pJC184c-rrnB and 
either pJC173e4 (for T7 promoter activity) or pJC174e4 (for T3 promoter activity).  Cells 
were grown to log phase and 20 µL aliquots were distributed into a deep-well plate.  10 
µL of  phage aliquots were added to these wells and plates were incubated in the warm 
room for 15 min.  Wells were then supplemented with 500 µL media, grown to mid-log 
phase, and cells were transferred to a microplate for luminescence measurement.
5.3.4 Gene expression properties of forward mutants
 Cells for luminescence assays were DH10B S1030 containing an expression 
plasmid (expressing a subcloned forward mutant of T7 RNAP) and either pJC173e4 (for 
T7 promoter activity) or pJC174e4 (for T3 promoter activity).  Cultures were grown 
overnight and used to seed 500 uL cultures in 96-well blocks that were grown to mid-log 
phase, after which cells were transferred to a microplate for luminescence measurement.
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